SciELO - Scientific Electronic Library Online

 
vol.20 número6Determinação das diferentes estirpes de Clostridium difficile num grupo de doentes com infecção causada por esta bactéria índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Jornal Português de Gastrenterologia

versión impresa ISSN 0872-8178

Resumen

AREIA, Miguel; PEREIRA, António Dias; BANHUDO, António  y  COUTINHO, Graça. Non-steroidal anti-inflammatory drugs and gastroprotection gap among Family Physicians: Results from a survey. J Port Gastrenterol. [online]. 2013, vol.20, n.6, pp.243-249. ISSN 0872-8178.  https://doi.org/10.1016/j.jpg.2012.11.004.

Introduction: Use of non-steroidal anti-inflammatory drugs (NSAIDs) has increased over the last few years and identification of gastrointestinal risk factors is a key factor for prevention of its complications. Even after correct identification of those risk factors, only a small percentage of Family Physicians prescribe gastroprotection. Aims: To knowledge gastrointestinal risk factors and gastroprotection’s prescription by Family Physicians in patients receiving NSAIDs. Methods: Observational, cross-sectional, random sample study, using a survey among 300 Family Physicians, performed in 2007. Questions were asked about perceived patients rates or hypothetical scenarios and answers were valued on an intention-to-treat basis. The main outcome measure was the gastroprotection’s prescription rate among patients taking NSAIDs. Results: The perceived proportion of patients receiving NSAIDs was 38% and from these, 40% were taking gastroprotective drugs. The main identified gastrointestinal risk factors were: complicated peptic ulcer (98%), age ≥ 65 years (96%), smoking habits and alcohol consumption (96%), dyspepsia (95%), high-doses of NSAIDs (94%), corticosteroids co-administration (91%) and consumption of two or more NSAIDs (90%). Gastroprotection would be prescribed in 82% of patients with history of complicated peptic ulcer; 60% if receiving two or more or a high dose of NSAIDs; 53% if with Helicobacter pylori infection and 51% if aged ≥ 65 years. For all risk factors, gastroprotection use would be only of 47.3% (95% confidence interval: 45.6-49.0%). Conclusions: Family Physicians are aware of NSAIDs’ gastrointestinal toxicity but risk estimation seems inadequate since they will not prescribe gastrointestinal protection in more than half the cases.

Palabras clave : Nonsteroidal/adverse effects; Aspirin/adverse effects; Peptic ulcer/prevention & control; Risk factors; Primary health care.

        · resumen en Portugués     · texto en Inglés     · Inglés ( pdf )